Suppr超能文献

[肝硬化所致糖尿病与其他2型糖尿病的鉴别诊断]

[Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2 diabetes mellitus].

作者信息

Kim Min Geun, Choi Won Choong

机构信息

Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.

出版信息

Korean J Hepatol. 2006 Dec;12(4):524-9.

Abstract

BACKGROUND/AIM: The liver plays important roles in the homeostasis of glucose metabolism since it acts as a major target organ for insulin and a site for gluconeogenesis and glycogen storage. Diabetes mellitus (DM) commonly develops in patients with liver cirrhosis as the result of hepatocyte dysfunction and/or inadequate mass. To assess differences between DM due to liver cirrhosis (hepatogenous DM) and the other type 2 DM, we compared the patterns of hyperglycemia and hyperinsulinemia in hepatogenous DM with those observed in type 2 DM.

METHODS

18 diabetic patients with liver cirrhosis (caused by alcohol, n=8; HBV, n=5; HCV, n=2; others, n=3) were matched with 18 type 2 diabetic patients without liver cirrhosis for age and gender. None of the patients or controls had been treated with insulin or beta-blockers. The level of glycosylated hemoglobin (HbA1C), fasting plasma glucose (FPG), postprandial plasma glucose (PP2h), fasting plasma C-peptide and insulin were measured.

RESULTS

The ratio of PP2h/FPG (2.27 vs. 1.69), fasting insulin (23.2: 11.6 microIU/mL) and HOMA-IR index (8.38 vs. 3.52) were significantly higher in hepatogenous DM than the other type 2 DM (P<0.05). PP2h, fasting C-peptide and ratio of fasting insulin/C-peptide tend to be higher in hepatogenous DM than those of controls, but which were not statistically significant.

CONCLUSIONS

The ratio of PP2h/FPG and fasting plasma insulin differentiated hepatogenous DM from the other type 2 DM. Insulin resistance in liver cirrhosis was higher than the other type 2 DM, and impaired hepatic insulin degradation might be an important mechanism of hyperinsulinemia in liver cirrhosis.

摘要

背景/目的:肝脏在葡萄糖代谢稳态中发挥重要作用,因为它是胰岛素的主要靶器官以及糖异生和糖原储存的场所。糖尿病(DM)在肝硬化患者中很常见,这是肝细胞功能障碍和/或肝组织量不足的结果。为了评估肝硬化所致糖尿病(肝源性糖尿病)与其他2型糖尿病之间的差异,我们比较了肝源性糖尿病与2型糖尿病患者的高血糖和高胰岛素血症模式。

方法

18例肝硬化糖尿病患者(酒精性肝硬化8例、乙肝肝硬化5例、丙肝肝硬化2例、其他原因肝硬化3例)与18例无肝硬化的2型糖尿病患者按年龄和性别进行匹配。所有患者及对照均未接受过胰岛素或β受体阻滞剂治疗。检测糖化血红蛋白(HbA1C)、空腹血糖(FPG)、餐后2小时血糖(PP2h)、空腹血浆C肽和胰岛素水平。

结果

肝源性糖尿病患者的PP2h/FPG比值(2.27对1.69)、空腹胰岛素水平(23.2:11.6微国际单位/毫升)和HOMA-IR指数(8.38对3.52)显著高于其他2型糖尿病患者(P<0.05)。肝源性糖尿病患者的PP2h、空腹C肽及空腹胰岛素/C肽比值往往高于对照组,但差异无统计学意义。

结论

PP2h/FPG比值和空腹血浆胰岛素水平可区分肝源性糖尿病与其他2型糖尿病。肝硬化患者的胰岛素抵抗高于其他2型糖尿病患者,肝脏胰岛素降解受损可能是肝硬化患者高胰岛素血症的重要机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验